comparemela.com

Lek Consulting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China s new NRDL adds 126 new drugs and cuts prices by 61 7% on average

Chinese patients will soon have wider access to newly approved cancer drugs following the publication of the 2024 National Reimbursement Drug List (NRDL) that added 126 new drugs to the list. Price cuts to drugs averaged 61.7%. The additions and cuts are in line with the previous year.

Authentic Climate Impact: Solving For The Right Problem

Only 42% of S&P 500 companies have concrete science-based targets. It s a daunting realization for any CEO: many organizations are solving the wrong problem.

china: China is full of risks, so why can t corporate America leave?

American companies doing business in China are facing increasing pressures and risks. The country s economy is struggling, and its relationship with the United States is strained. The economic outlook has also worsened, making it harder for companies to justify investing in China. However, many companies still see their China operations as a long-term bet, despite the hazards.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.